Genovate Biotechnology Co., Ltd. (TPEX:4130)

Taiwan · Delayed Price · Currency is TWD

26.70

-0.10 (-0.37%)

Inactive · Last trade price on Jul 21, 2026

Genovate Biotechnology Financials Overview

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	471.48	492.41	510.86	528.51	438.76	434.25
Revenue Growth	-6.23%	-3.61%	-3.34%	20.46%	1.04%	-8.14%
Gross Profit	163.03	177.02	192.65	210.92	154.87	149.75
Operating Income	-17.22	6.92	23.43	27.01	-13.89	-1.17
Net Income	-9.17	11.68	25.7	29.33	-12.32	0.37
Earnings Per Share	-0.08	0.10	0.22	0.25	-0.11	0.00
EPS Growth	-	-54.55%	-13.69%	-	-	-99.15%

Revenue by Geography

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Taiwan	483.82	505.74	519.35	435.22	429.86
Other	8.58	5.12	9.16	3.54	4.4
Total	492.41	510.86	528.51	438.76	434.25

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	1,111	481.96	521.47	539.3	497.05	389.42
Total Debt	1.57	1.84	2.58	0.68	1.84	0.83
Net Cash (Debt)	1,109	480.12	518.88	538.62	495.21	388.59
Net Cash Growth	119.86%	-7.47%	-3.66%	8.77%	27.44%	-7.29%
Net Cash Per Share	9.45	4.22	4.52	4.68	4.37	3.43

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	1.81	43.79	55.11	84.78	1.51	-17.26
Capital Expenditures	-38.1	-55.73	-30.78	-27.98	-23.55	-17.96
Free Cash Flow	-36.29	-11.94	24.34	56.81	-22.04	-35.22
Free Cash Flow Growth	-	-	-57.16%	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	34.58%	35.95%	37.71%	39.91%	35.30%	34.48%
Operating Margin	-3.65%	1.40%	4.59%	5.11%	-3.17%	-0.27%
Pretax Margin	-2.15%	2.73%	6.08%	5.83%	-2.05%	0.82%
Profit Margin	-1.94%	2.37%	5.03%	5.55%	-2.81%	0.09%
FCF Margin	-7.70%	-2.42%	4.76%	10.75%	-5.02%	-8.11%

Dividends

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 11, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Dividend Per Share	0.098	-	0.100	0.143	0.167	0.333
Dividend Per Share Growth	-32.00%	-	-29.97%	-14.29%	-49.98%	-12.94%
Dividend Yield	0.37%	-	0.51%	0.59%	0.57%	1.50%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 11, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	-	269.72	90.45	99.18	-	7191.72
Forward PE	-	38.71	38.71	38.71	38.71	38.71
P/FCF Ratio	-	-	95.52	51.22	-	-
PS Ratio	7.74	6.40	4.55	5.51	7.99	6.16